Estimation of direct and indirect costs of coronary heart disease in Shahid Madani Hospital, Tabriz

Abstract

Abstract Background: Despite many improvementscardiovascular, disease is the one leading cause of death in in many countries including Iran.Therefore; this study aimed to estimate systematically analyzed those costs and the annual economic burden of coronary heart disease (CHD) in Iran in 2016. Materials and methods: The analysis used the cost of illness (COI) framework, cross-sectional and was based on a prevalence-based, study using a researcher-made checklist over a six-month period. A bottom up approach and social perspective was used to estimate the economic burden of 379 patients CHD and costs were reported in terms of purchase power parity index. Data were analyzed using SPSS 24 software. Results: Total costs per patient in one year were estimated to be 63452290.17 IRR (7736.19 $PPP) at a 95% confidence interval (58191511.73-68713068.60), the biggest part of which is related to direct medical costs with 33884019.53 IRR per year (4131.18 $PPP) (54%). Direct non-medical costs were estimated 1655936.68 IRR (201.89$ PPP) per patient (2%) and indirect costs were estimated 27912333.97 IRR per patient (3403.11$ PPP) (44%), which 62% of indirect costs is related to patients’ work absenteeism. Conclusion: This study estimates the direct (56%) and indirect (44%) costs associated with coronary artery disease. The study explores the essential drivers of the costs, and provides the magnitude of the burden in terms of the share of GDP. The outcomes of this study can be used in priority setting, in particular for cost benefit analysis, and adopting new policies regarding insurance coverage and equity issues.